Chemomab Therapeutics Ltd Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| CITADEL ADVISORS LLC | 09/02/2026 | 95.31 K | $154.40 K | 48.50% | 1.19% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 08/14/2026 | 80.00 K | $129.60 K | 0.00% | 1.00% |
| KESTRA PRIVATE WEALTH SERVICES, LLC | 07/28/2026 | 61.71 K | $99.97 K | 0.00% | 0.77% |
| IKARIAN CAPITAL, LLC | 08/14/2026 | 51.79 K | $83.90 K | 0.00% | 0.65% |
| RHUMBLINE ADVISERS | 08/12/2026 | 30.53 K | $49.46 K | 66.23% | 0.38% |
| XTX TOPCO LTD | 08/14/2026 | 15.99 K | $25.90 K | -14.18% | 0.20% |
| PHILADELPHIA INVESTMENT PARTNERS, LLC | 08/14/2026 | 15.00 K | $24.30 K | 82.93% | 0.19% |
| LIDO ADVISORS, LLC | 08/07/2026 | 14.34 K | $23.23 K | 100.00% | 0.18% |
| BNP PARIBAS ARBITRAGE, SNC | 08/13/2026 | 6.81 K | $11.02 K | -19.23% | 0.09% |
| GAMMA INVESTING LLC | 07/07/2026 | 4.74 K | $7.68 K | -37.46% | 0.06% |
| MORGAN STANLEY | 08/13/2026 | 3.58 K | $5.79 K | -21.86% | 0.04% |
| SBI SECURITIES CO., LTD. | 07/23/2026 | 34 | $55 | 21.43% | 0.00% |
| CAITONG INTERNATIONAL ASSET MANAGEMENT CO., LTD | 08/05/2026 | 8 | $13 | 0.00% | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/14/2026 | 0 | $0 | -100.00% | 0.00% |
| UBS GROUP AG | 08/13/2026 | 0 | $0 | -100.00% | 0.00% |
| SMARTHARVEST PORTFOLIOS, LLC | 08/04/2026 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Chemomab Therapeutics Ltd institutional Ownership - FAQ's
During the previous two years, 19 institutional investors and hedge funds held shares of Chemomab Therapeutics Ltd. The most heavily invested institutionals were:
CITADEL ADVISORS LLC: 95,311
ADAR1 Capital Management, LLC: 80,000
KESTRA PRIVATE WEALTH SERVICES, LLC: 61,710
Ikarian Capital, LLC: 51,793
RHUMBLINE ADVISERS: 30,529
XTX Topco Ltd: 15,987
4.75% of Chemomab Therapeutics Ltd stock is owned by institutional investors.
Institutional investors have bought a total of 405.92 K shares in the last 24 months. This purchase volume represents approximately $811.84 K in transactions.